Waters CORP /DE/ 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE

23 Feb 2026

WAT

10-K: Waters Corp. Reports 7% Sales Growth, Integrates BDS Business

Waters Corporation announced a 7% increase in net sales for 2025, alongside the transformative $16.8 billion acquisition of BD's Biosciences and Diagnostic Solutions businesses, significantly expanding its market presence.

NYSE

25 Feb 2025

WAT

Waters CORP /DE/

10-K: Waters Corporation Reports Flat Revenue in 2024, Cites China Slowdown

Waters Corporation's 2024 revenue remained flat year-over-year, primarily due to a significant decline in sales from China, despite growth in other geographic regions.

NYSE

27 Feb 2024

WAT

Waters CORP /DE/

10-K: Waters Corporation 2023 10-K Filing: Navigating Global Headwinds and Strategic Acquisitions

Waters Corporation's 2023 10-K filing reveals a year of mixed results, marked by a decline in sales in China, strategic acquisitions, and ongoing investments in research and development.